Imatinib mesylate 400mg capsule (DrugBank: Imatinib)
12 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
13 | 多発性硬化症/視神経脊髄炎 | 0 |
28 | 全身性アミロイドーシス | 0 |
34 | 神経線維腫症 | 0 |
35 | 天疱瘡 | 0 |
46 | 悪性関節リウマチ | 0 |
51 | 全身性強皮症 | 0 |
85 | 特発性間質性肺炎 | 0 |
86 | 肺動脈性肺高血圧症 | 0 |
87 | 肺静脈閉塞症/肺毛細血管腫症 | 0 |
88 | 慢性血栓塞栓性肺高血圧症 | 0 |
89 | リンパ脈管筋腫症 | 1 |
162 | 類天疱瘡(後天性表皮水疱症を含む。) | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03131999 (ClinicalTrials.gov) | January 23, 2018 | 24/4/2017 | LAM Pilot Study With Imatinib Mesylate | LAM Pilot Study With Imatinib Mesylate | Lymphangioleiomyomatosis | Drug: Imatinib Mesylate 400Mg Capsule;Drug: Placebo - Capsule | Medical University of South Carolina | Columbia University | Completed | 18 Years | N/A | All | 18 | Phase 1;Phase 2 | United States |